A chest X-ray performed during that admission did not show evidence of pneumonia.
He was also started on Augmentin for treatment of a pan-sensitive enterococcal UTI that was noted on UA and urine cultures.
His Coumadin was held on discharge for a supra-therapeutic INR with plans to restart it opnce his INR dropped below 3.0.
In the ED, his initial vital signs were as follows: BP 121/88, HR 94, RR 18, and SpO2 99% on 6L (SpO2 85% on room air).
His CXR showed new opacities in the RUL field and LLL.
EKG showed AFib at 108 bpm with baseline artifact and lateral TWI.
Labs were notable for a newly elevated WBC count 15.1 (7.1 the day before) with 5% bands.
His Troponin T was elevated to 0.13, higher than recent values at his last admission with normal CKMB.
His INR was 3.1, consistent with his recent trend with Coumadin held.
He was admitted to the ICU for further management of pneumonia and a COPD exacerbation.
His course was complicated by delirium and he failed a bedside speech and swallow evaluation on [**2-19**].
Past Medical History: # COPD -- on intermittent home O2 (does not use routinely) # Chronic Diastolic CHF -- last echo on [**2102-7-27**] showed LVEF 45-50% -- mild regional left ventricular systolic dysfunction -- severe hypokinesis of inferior wall and septum (c/w RCA disease) # CAD -- s/p CABG at [**Hospital3 **] Medical Center in [**2080**] -- s/p subsequent PCI/stent procedure at [**Hospital3 **] -- no cath since around [**2093**] # Atrial fibrillation on Coumadin # Ascending aortic aneurysm # Hypertension # Hyperlipidemia # TIA ([**2079**]) -- residual decreased hearing in left ear # Prostate cancer -- treated s/p leuprolide: d/c'ed tx early 10 yrs ago # Osteoporosis # Gastroesophageal reflux disease  Social History: Cantonese speaking with minimal English.
Physical Exam: VS: T 97.6, BP 92/49, HR 103, RR 26, SpO2 97% on 50% face tent Gen: Elderly male with increased work of breathing.
Pertinent Results: Admission Laboratory Studies: [**2106-2-17**] 04:12PM BLOOD WBC-15.1*# (Neuts-84* Bands-5 Lymphs-4* Monos-7 Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0) RBC-4.80 Hgb-14.8 Hct-45.0 MCV-94 MCH-30.8 MCHC-32.8 RDW-13.8 Plt Ct-218 [**2106-2-17**] 04:12PM BLOOD [**2106-2-17**] 04:12PM BLOOD PT-31.1* PTT-41.1* INR(PT)-3.1* [**2106-2-17**] 04:12PM BLOOD Glucose-158* UreaN-92* Creat-2.6* Na-140 K-4.4 Cl-103 HCO3-28 AnGap-13 [**2106-2-17**] 04:12PM BLOOD cTropnT-0.13* [**2106-2-18**] 11:02AM BLOOD Lactate-3.4*  Other Notable Laboratory Studies: [**2106-2-17**] 11:50PM BLOOD CK-MB-4 cTropnT-0.11* [**2106-2-18**] 05:00AM BLOOD CK-MB-4 cTropnT-0.09* [**2106-2-18**] 04:47PM BLOOD Lactate-2.4*  Discharge Laboratory Studies:  Microbiology: [**2106-2-18**] URINE CULTURE-NO GROWTH [**2106-2-18**] BLOOD CULTURE-NO GROWTH [**2106-2-18**] BLOOD CULTURE-NO GROWTH  Radiographic Studies: [**2106-2-17**] Portable Chest X-Ray: IMPRESSION: In comparison to [**2106-2-13**] exam, there is development new of right upper zone patchy opacities and left lower lobe opacity concerning for multifocal pneumonia.
[**2106-2-26**]: Frontal chest radiograph is compared to multiple prior examinations.
Echo [**2-25**]: The left atrium is dilated.
Compared with the report of the prior study (images unavailable for review) of [**2102-7-27**], left ventricular systolic function is now more depressed.
[**2106-2-26**] 09:46PM BLOOD WBC-8.8 RBC-4.04* Hgb-12.0* Hct-38.6* MCV-96 MCH-29.7 MCHC-31.0 RDW-14.8 Plt Ct-184  Brief Hospital Course: He was admitted to the MICU due to respiratory distress from Health-care associated pneumonia which was managed with BIPAP and did not require intubation.
However, he developed volume overload and acute systolic heart failure and worsening SOB with BNP > 7000.
Echocardiogram revealed depressed LVEF 40% (new) with worsening valve disease and regional abnormalities.
EEG did not show any seizure activity.
His diarrhea did not improve and did not progress (4 BMs daily loose without water diarrhea).
In regards to his chronic kidney disease stage 3-4 with an eGFR around 30, he was in acute renal failure on admission with peak creatinine of 2.9 which improved after IVF and remained stable.
Medications on Admission: Normal Home Medications (on arrival to the floor, this list was confirmed with his son, [**Name (NI) **], who administers medications): Aspirin 81 mg PO daily Atorvastatin 10 mg PO daily Metoprolol tartrate 50 mg PO BID Spironolactone 12.5 mg PO daily Bumetanide 4 mg PO BID Fluticasone-Salmeterol (250-50 mcg) 1 IH [**Hospital1 **] Levalbuterol (0.63 mg/3 mL) neb Q6H PRN SOB Ipratropium (0.02%) 1-2 puffs IH Q6H Ranitidine HCl 150 mg PO daily  Recent Discharge Medications: Augmentin (500-125 mg) 1 tab PO Q12H for 6 days until [**2106-2-22**] Aspirin 81 mg PO daily Atorvastatin 10 mg PO daily Metoprolol tartrate 50 mg PO BID Spironolactone 12.5 mg PO daily Bumetanide 4 mg PO BID Nitroglycerin 0.4 mg SL PRN chest pain Fluticasone-Salmeterol (250-50 mcg) 1 IH [**Hospital1 **] Levalbuterol (0.63 mg/3 mL) neb Q6H PRN SOB Ipratropium (0.02%) 1-2 puffs IH Q6H Ranitidine HCl 150 mg PO daily Protonix 40 mg PO daily Acetaminophen 650 mg PO TID PRN pain Docusate sodium 100 mg PO BID PRN constipation Senna 8.6 mg PO QHS PRN constipation Tamsulosin 0.4 mg PO QHS Humalog ISS (2 units for every 50 units above 151) Heparin 5,000 units SC TID Prednisone taper -- [**Date range (1) 20443**]: 40 mg daily -- [**Date range (1) 10649**]: 20 mg daily -- [**Date range (1) 61076**]: 10 mg daily   Discharge Medications: 1. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
You developed confusion and underwent extensive neurologic evaluation which was negative for acute stroke.
